Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Late-Stage Pipeline

25%

1 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A
2(50.0%)
Phase 3
1(25.0%)
Phase 2
1(25.0%)
4Total
N/A(2)
Phase 3(1)
Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT05454072Not ApplicableActive Not Recruiting

Microbiota Transfer for Chronic Rhinosinusitis

Role: lead

NCT07383415Not ApplicableNot Yet Recruiting

Intranasal Platelet-Rich Plasma With or Without Topical Insulin for Post-Inflammatory Anosmia

Role: lead

NCT07383402Phase 3Not Yet Recruiting

Intra-Sinus Povidone-Iodine and Budesonide After Endoscopic Sinus Surgery for Chronic Rhinosinusitis

Role: lead

NCT06456255Phase 2Recruiting

Bupivacaine and Epinephrine Injection Study

Role: lead

All 4 trials loaded